Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
Ratjen F, Döring G, Nikolaizik WH. Ratjen F, et al. Among authors: nikolaizik wh. Lancet. 2001 Sep 22;358(9286):983-4. doi: 10.1016/S0140-6736(01)06124-4. Lancet. 2001. PMID: 11583754
Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis.
Nikolaizik WH, Trociewicz K, Ratjen F. Nikolaizik WH, et al. Eur Respir J. 2002 Jul;20(1):122-6. doi: 10.1183/09031936.02.00264002. Eur Respir J. 2002. PMID: 12166559 Free article. Clinical Trial.
Aerosol therapy in patients with cystic fibrosis.
Schöni MH, Nikolaizik WH. Schöni MH, et al. Among authors: nikolaizik wh. Schweiz Med Wochenschr. 1997 Feb 1;127(5):158-64. Schweiz Med Wochenschr. 1997. PMID: 9042684 Review.
Bronchial constriction after nebulized tobramycin preparations and saline in patients with cystic fibrosis.
Nikolaizik WH, Jenni-Galović V, Schöni MH. Nikolaizik WH, et al. Eur J Pediatr. 1996 Jul;155(7):608-11. doi: 10.1007/BF01957914. Eur J Pediatr. 1996. PMID: 8831087
Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis.
Nikolaizik WH, Schöni MH. Nikolaizik WH, et al. J Pediatr. 1996 Feb;128(2):271-4. doi: 10.1016/s0022-3476(96)70407-9. J Pediatr. 1996. PMID: 8636828 Clinical Trial.
A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients.
Nikolaizik WH, Vietzke D, Ratjen F. Nikolaizik WH, et al. Can Respir J. 2008 Jul-Aug;15(5):259-62. doi: 10.1155/2008/202464. Can Respir J. 2008. PMID: 18716688 Free PMC article. Clinical Trial.
Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis.
Bald M, Ratjen F, Nikolaizik W, Wingen AM. Bald M, et al. Pediatr Infect Dis J. 2001 Mar;20(3):320-1. doi: 10.1097/00006454-200103000-00024. Pediatr Infect Dis J. 2001. PMID: 11303842
DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha.
Ratjen F, Paul K, van Koningsbruggen S, Breitenstein S, Rietschel E, Nikolaizik W. Ratjen F, et al. Pediatr Pulmonol. 2005 Jan;39(1):1-4. doi: 10.1002/ppul.20134. Pediatr Pulmonol. 2005. PMID: 15532079 Clinical Trial.
Effect of 3 weeks' rehabilitation on neutrophil surface antigens and lung function in cystic fibrosis.
Nikolaizik WH, Simon HU, Iseli P, Blaser K, Schöni MH. Nikolaizik WH, et al. Eur Respir J. 2000 May;15(5):942-8. doi: 10.1034/j.1399-3003.2000.15e22.x. Eur Respir J. 2000. PMID: 10853863 Free article.
Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy.
Hemmann S, Nikolaizik WH, Schöni MH, Blaser K, Crameri R. Hemmann S, et al. Among authors: nikolaizik wh. Eur J Immunol. 1998 Apr;28(4):1155-60. doi: 10.1002/(SICI)1521-4141(199804)28:04<1155::AID-IMMU1155>3.0.CO;2-6. Eur J Immunol. 1998. PMID: 9565354 Free article.
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback